Requests that FDA declare that Metformin HCl for Extended-Release Oral Suspension, 500 mg and 750 mg (unit-dose sachets), are suitable for submission as an ANDA
🏛 Food and Drug Administration (FDA)FDA-2026-P-4535
Documents
3
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
📄 Primary document
- Other· Apr 23, 2026No comment period